Related Experiment Video
Updated: Sep 17, 2025

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
MicroRNA-361-3p Regulates Autophagy and Apoptotic Processes by Regulating PI3K/Akt Signaling in Parkinson's Disease
Pingting Chen1, Jing Yang2, Yixuan Xu2
1Department of Neurology, Wenling TCM Hospital Affiliated to Zhejiang Chinese Medical University, Taizhou, 317500, China.
Abstract:
MicroRNAs are closely related to the pathogenesis of Parkinson's disease (PD). The purpose of this study was to explore the effects of microRNA (miR)-361-3p on apoptosis and autophagy in 1-methyl-4-phenylpyridinium ion (MPP+) induced PD cell models, and its potential mechanisms. SH-SY5Y cells were induced by 1.0 mM MPP+ for 24 h to establish a PD cell model in vitro, and the expression level of miR-361-3p was regulated by cell transfection. Cell viability was detected by the Cell Count Kit (CCK)-8 method. Apoptosis was evaluated by flow cytometry. Inflammatory factors were detected by enzyme-linked immunosorbent assay (ELISA). The changes of autophagy-associated proteins (Beclin 1, LC3I, and LC3II) and PI3K/Akt signaling pathway-associated proteins (p-PI3K and p-Akt) were detected by Western blot. The target genes of miR-361-3p were predicted and functionally annotated by the bioinformatics method. The interaction between miR-361-3p and its target gene PFKFB3 was verified by the luciferase reporter gene. With the increase of MPP+ concentrations, the expression level of miR-361-3p and cell viability decreased gradually. In MPP+ induced SH-SY5Y cells, upregulation of miR-361-3p significantly improved cell survival and reduced apoptosis, while downregulating autophagy protein Beclin 1, LC3II/LC3I ratio, and increasing proteins p-PI3K/PI3K and p-Akt/Akt ratio. In addition, upregulation of miR-361-3p inhibited the expression of PFKFB3, while further overexpression of PFKFB3 negated the protective effect of miR-361-3p overexpression on MPP+ induced cells. This study showed that miR-361-3p was reduced in the PD cell model, and overexpression of miR-361-3p inhibited PD damage by regulating PFKFB3 and activating the PI3K/Akt signaling pathway.
Insights
MicroRNA-361-3p protects against Parkinson's disease (PD) by reducing cell death and apoptosis. Upregulating this microRNA inhibits PD progression by targeting PFKFB3 and activating the PI3K/Akt pathway.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) play a crucial role in the pathogenesis of Parkinson's disease (PD).
- Understanding the specific roles of miRNAs in PD is essential for developing targeted therapies.
- Dysregulation of cellular processes like apoptosis and autophagy is implicated in PD.
Purpose of the Study:
- To investigate the effect of microRNA (miR)-361-3p on apoptosis and autophagy in a Parkinson's disease (PD) cell model.
- To elucidate the underlying molecular mechanisms of miR-361-3p in PD pathogenesis.
- To explore the potential of miR-361-3p as a therapeutic target for PD.
Main Methods:
- Established an in vitro Parkinson's disease (PD) cell model using SH-SY5Y cells induced by 1-methyl-4-phenylpyridinium ion (MPP+).
- Manipulated miR-361-3p expression via cell transfection and assessed cell viability (CCK-8), apoptosis (flow cytometry), and inflammatory factors (ELISA).
- Analyzed autophagy-associated proteins (Beclin 1, LC3) and PI3K/Akt signaling pathway proteins (p-PI3K, p-Akt) using Western blot; verified miR-361-3p target gene (PFKFB3) interaction via luciferase reporter assay.
Main Results:
- MPP+ treatment decreased miR-361-3p expression and cell viability in a dose-dependent manner.
- Overexpression of miR-361-3p significantly enhanced cell survival, reduced apoptosis, and modulated autophagy proteins (decreased Beclin 1, LC3II/LC3I ratio) in MPP+-induced cells.
- miR-361-3p upregulation inhibited PFKFB3 expression, and subsequent PFKFB3 overexpression reversed the protective effects of miR-361-3p, while activating the PI3K/Akt pathway.
Conclusions:
- miR-361-3p expression is reduced in Parkinson's disease (PD) cell models.
- Overexpression of miR-361-3p exerts neuroprotective effects by inhibiting apoptosis and modulating autophagy.
- miR-361-3p functions via regulating PFKFB3 and activating the PI3K/Akt signaling pathway, offering a potential therapeutic strategy for PD.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The JAK-STAT Signaling Pathway